| Name | Title | Type |
|---|---|---|
| Kathleen Broadhurst | Sr. Director of Finance | Auditee |
| Kari Young | Partner/Shareholder | Auditee |
| Kathleen Broadhurst | Sr. Director of Finance | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 324275 | 2024 | 2024-10-09 | Jones & Roth PC | $2.06M |
| 7706 | 2023 | 2023-12-20 | Jones & Roth PC | $2.07M |
| 41842 | 2022 | 2023-03-23 | Jones & Roth PC | $2.08M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 324275 | 2024 | 2024-10-09 | 1078530 | 2024-003 | Material Weakness | - | N |
| 324275 | 2024 | 2024-10-09 | 1078529 | 2024-002 | Significant Deficiency | Yes | L |
| 324275 | 2024 | 2024-10-09 | 1078528 | 2024-001 | Material Weakness | Yes | E |
| 324275 | 2024 | 2024-10-09 | 502088 | 2024-003 | Material Weakness | - | N |
| 324275 | 2024 | 2024-10-09 | 502087 | 2024-002 | Significant Deficiency | Yes | L |
| 324275 | 2024 | 2024-10-09 | 502086 | 2024-001 | Material Weakness | Yes | E |
| 7706 | 2023 | 2023-12-20 | 582149 | 2023-005 | Significant Deficiency | - | ABN |
| 7706 | 2023 | 2023-12-20 | 582148 | 2023-004 | Significant Deficiency | - | N |
| 7706 | 2023 | 2023-12-20 | 582147 | 2023-003 | Significant Deficiency | - | N |
| 7706 | 2023 | 2023-12-20 | 582146 | 2023-002 | Significant Deficiency | - | L |
| 7706 | 2023 | 2023-12-20 | 582145 | 2023-001 | Material Weakness | Yes | E |
| 7706 | 2023 | 2023-12-20 | 5707 | 2023-005 | Significant Deficiency | - | ABN |
| 7706 | 2023 | 2023-12-20 | 5706 | 2023-004 | Significant Deficiency | - | N |
| 7706 | 2023 | 2023-12-20 | 5705 | 2023-003 | Significant Deficiency | - | N |
| 7706 | 2023 | 2023-12-20 | 5704 | 2023-002 | Significant Deficiency | - | L |
| 7706 | 2023 | 2023-12-20 | 5703 | 2023-001 | Material Weakness | Yes | E |
| 41842 | 2022 | 2023-03-23 | 627200 | 2022-002 | Material Weakness | - | E |
| 41842 | 2022 | 2023-03-23 | 50758 | 2022-002 | Material Weakness | - | E |